Norges Bank
RAPT

Norges Bank’s RAPT Therapeutics RAPT Stock Holding History

Norges Bank’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,538
Closed -$306K – 1939
2024
Q2 		$306K Hold
12,538
– – ﹤0.01% 1904
2024
Q1 		$901K Hold
12,538
– – ﹤0.01% 1802
2023
Q4 		$2.49M Buy
+12,538
New +$1.55M ﹤0.01% 1775
2023
Q2 		– Sell
-12,263
Closed -$1.8M – 2093
2023
Q1 		$1.8M Sell
12,263
-20,012
-62% -$4.05M ﹤0.01% 1938
2022
Q4 		$5.11M Buy
+32,275
New +$5.17M ﹤0.01% 1777
2022
Q1 		– Sell
-12,325
Closed -$3.62M – 2219
2021
Q4 		$3.62M Sell
12,325
-17,763
-59% -$4.75M ﹤0.01% 1969
2021
Q3 		$7.47M Buy
30,088
+24,300
+420% +$6.42M ﹤0.01% 1843
2021
Q2 		$1.47M Buy
+5,788
New +$1.08M ﹤0.01% 2056
2020
Q4 		– Sell
-3,750
Closed -$966K – 2154
2020
Q3 		$966K Buy
+3,750
New +$832K ﹤0.01% 2033
2020
Q1 		– Sell
-3,750
Closed -$828K – 2069
2019
Q4 		$828K Buy
+3,750
New +$690K ﹤0.01% 2032

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Norges Bank's RAPT Position: Q3 2024 in Review

Norges Bank sold out of RAPT Therapeutics (RAPT) in Q3 2024, closing a stake of 12,538 shares — an estimated $306K sold.

Norges Bank first reported a position in RAPT in Q4 2019 and held it in 10 quarters. The position peaked at $7.47M in Q3 2021. 94 funds tracked by Wall St. Rank hold RAPT as of Q3 2024.

  • Norges Bank reported no remaining RAPT Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Norges Bank sold 12,538 RAPT Therapeutics shares in Q3 2024, an estimated $306K.
  • Norges Bank first reported a position in RAPT Therapeutics in Q4 2019 and held it in 10 quarters.
  • Norges Bank's RAPT Therapeutics position peaked at $7.47M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.